These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18568800)

  • 1. Double-blind placebo-controlled provocation study in patients with subjective Multiple Chemical Sensitivity (MCS) and matched control subjects.
    Bornschein S; Hausteiner C; Römmelt H; Nowak D; Förstl H; Zilker T
    Clin Toxicol (Phila); 2008 Jun; 46(5):443-9. PubMed ID: 18568800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple chemical sensitivity in male painters; a controlled provocation study.
    Georgellis A; Lindelöf B; Lundin A; Arnetz B; Hillert L
    Int J Hyg Environ Health; 2003 Oct; 206(6):531-8. PubMed ID: 14626900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Multiple chemical sensitivities: case definition, etiology and relations to allergy, poisoning, psychogenic illness etc].
    Araki S; Sakai T; Sato H; Kaneko T; Sakai R; Yokoyama K
    Nihon Koshu Eisei Zasshi; 1999 Sep; 46(9):769-78. PubMed ID: 10540848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical sensitivity attributed to pesticide exposure versus remodeling.
    Miller CS; Mitzel HC
    Arch Environ Health; 1995; 50(2):119-29. PubMed ID: 7786048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of treatment with etizolam 0.5 mg BID on cognitive performance: a 3-week, multicenter, randomized, double-blind, placebo-controlled, two-treatment, three-period, noninferiority crossover study in patients with anxiety disorder.
    De Candia MP; Di Sciascio G; Durbano F; Mencacci C; Rubiera M; Aguglia E; Garavini A; Bersani G; Di Sotto A; Placidi G; Cesana BM
    Clin Ther; 2009 Dec; 31(12):2851-9. PubMed ID: 20110024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal chemoreception in patients with multiple chemical sensitivities: a double-blind investigation.
    Hummel T; Roscher S; Jaumann MP; Kobal G
    Regul Toxicol Pharmacol; 1996 Aug; 24(1 Pt 2):S79-86. PubMed ID: 8921561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychological test performance during experimental challenge to toluene and n-butyl acetate in cases of solvent-induced toxic encephalopathy.
    Osterberg K; Orbaek P; Karlson B; Seger L; Akesson B; Bergendorf U
    Scand J Work Environ Health; 2000 Jun; 26(3):219-26. PubMed ID: 10901114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptom profile of multiple chemical sensitivity in actual life.
    Saito M; Kumano H; Yoshiuchi K; Kokubo N; Ohashi K; Yamamoto Y; Shinohara N; Yanagisawa Y; Sakabe K; Miyata M; Ishikawa S; Kuboki T
    Psychosom Med; 2005; 67(2):318-25. PubMed ID: 15784800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of brain-directed nutrients on cerebral blood flow and neuropsychological testing: a randomized, double-blind, placebo-controlled, crossover trial.
    Amen DG; Taylor DV; Ojala K; Kaur J; Willeumier K
    Adv Mind Body Med; 2013; 27(2):24-33. PubMed ID: 23709409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical consequences of the EI/MCS "diagnosis": two paths.
    Staudenmayer H
    Regul Toxicol Pharmacol; 1996 Aug; 24(1 Pt 2):S96-110. PubMed ID: 8921563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind non-controlled chemical challenge with environmental toxicological assessment in a Multiple Chemical Sensitivity case.
    Ralph B; Martine O; Jacques R
    J Neurol Sci; 2011 Jul; 306(1-2):154-6. PubMed ID: 21496828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Riluzole and D-amphetamine interactions in humans.
    Sofuoglu M; Waters AJ; Mooney M; Kosten T
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):16-22. PubMed ID: 17714844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human drug discrimination and multiple chemical sensitivity: caffeine exposure as an experimental model.
    Eissenberg T; Griffiths RR
    Environ Health Perspect; 1997 Mar; 105 Suppl 2(Suppl 2):509-13. PubMed ID: 9167988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a brief questionnaire for screening for multiple chemical sensitivity syndrome.
    Hu H; Stern A; Rotnitzky A; Schlesinger L; Proctor S; Wolfe J
    Toxicol Ind Health; 1999 Oct; 15(6):582-8. PubMed ID: 10560136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of the mineralocorticoid receptor in healthy men: effects on experimentally induced panic symptoms, stress hormones, and cognition.
    Otte C; Moritz S; Yassouridis A; Koop M; Madrischewski AM; Wiedemann K; Kellner M
    Neuropsychopharmacology; 2007 Jan; 32(1):232-8. PubMed ID: 17035932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised, placebo-controlled trial of transcranial pulsed electromagnetic fields in patients with multiple chemical sensitivity.
    Tran MTD; Skovbjerg S; Arendt-Nielsen L; Christensen KB; Elberling J
    Acta Neuropsychiatr; 2017 Oct; 29(5):267-277. PubMed ID: 27919300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of cerebral blood flow in patients with multiple chemical sensitivity using near-infrared spectroscopy--recovery after olfactory stimulation: a case-control study.
    Azuma K; Uchiyama I; Tanigawa M; Bamba I; Azuma M; Takano H; Yoshikawa T; Sakabe K
    Environ Health Prev Med; 2015 May; 20(3):185-94. PubMed ID: 25682122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive effects of intravenous hydrocortisone in subjects with PTSD and healthy control subjects.
    Grossman R; Yehuda R; Golier J; McEwen B; Harvey P; Maria NS
    Ann N Y Acad Sci; 2006 Jul; 1071():410-21. PubMed ID: 16891588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind placebo and active (caffeine) controlled study to examine the effects of the herbal nutritional supplement beverage "Wake up" on vigilance and function after lunch.
    Kassis O; Katz N; Ravid S; Pillar G
    Isr Med Assoc J; 2013 Aug; 15(8):419-23. PubMed ID: 24079062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive deficits in schizophrenia are associated with alterations in blood levels of neurosteroids: a multiple regression analysis of findings from a double-blind, randomized, placebo-controlled, crossover trial with DHEA.
    Ritsner MS; Strous RD
    J Psychiatr Res; 2010 Jan; 44(2):75-80. PubMed ID: 19665142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.